ArticleThe Biochemical journal2025
Targeting calcineurin: a synergistic strategy with caspofungin to induce farnesol-mediated quorum sensing in Nakaseomyces glabrata-an inoculum-dependent tale.
Article in The Biochemical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Using Nakaseomyces glabrata as a model organism, we demonstrate that targeting calcineurin can synergize with caspofungin to induce a quorum sensing (QS) effect mediated by farnesol. This QS effect requires calcineurin deficiency, sub-minimum inhibitory concentration (MIC) levels of caspofungin, and a high-density cell population. Cell growth and biofilm formation were significantly inhibited within a specific range of cell density and sub-MIC caspofungin treatment in the calcineurin mutant. The inhibition of biofilm formation follows the 'paradoxical growth,' showing a concentration-dependent response to caspofungin. We show that high cell density triggers two antagonistic effects: overcoming antibiotic inhibition, which promotes cell propagation, and QS-mediated growth inhibition, which negatively regulates cell proliferation. The QS molecule farnesol was detectable only in the calcineurin mutant, where the transcription of the farnesol synthase Dpp3 was significantly up-regulated, and deletion of DPP3 abolished the QS effect in both spot assay and biofilm formation of the calcineurin mutant. Besides this, we identified a Dpp3-dependent, ergosterol-farnesol metabolism-linked Crz1-independent regulatory mechanism that contributes to the calcineurin-mediated multi-stress resistance. We demonstrate that calcineurin, Dpp3, and caspofungin are all involved in regulating ergosterol metabolism and the transcription of ERG11 and FKS genes, leading to significant changes in membrane and cell wall stress tolerance. The cell wall composition undergoes substantial alterations upon deletion of calcineurin or treatment with caspofungin, while caspofungin also increases the levels of β-glucan and short peptides in the medium, tentatively pointing to the release of QS inducers from the cell wall.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.